Cancer has become the leading cause of death in humans surpassing cardiovascular, metabolic and other diseases. Despite huge advancements in diagnosis and treatment of cancer, the five-year survival rate is still very low around the globe. Moreover, resistance to chemotherapeutic drugs/radiation therapy often leading to recurrence and relapse of cancer is the major global challenge that the whole world is facing. As predicted by the World Health Organisation (WHO), by 2030, every second individual will develop one or the other type of cancer. Therefore, there is an urgent need for rigorous research and innovation in the field of cancer biology to develop modern tools for early detection, identify relapse-free therapeutic